Selection bias

ICH M14 guideline on general principles on plan, design and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines Step 2b

Retrieved on: 
日曜日, 6月 2, 2024
Consensus, Sentinel, Real-World Evidence, NPV, Privacy, Smoking, Business analyst, Interest, Scope, Section 3, Missing data, Attention deficit hyperactivity disorder, World Health Organization, Thrombosis, Vaccination, Artificial intelligence, GVP, Element, ICD-10, ICD, Target, Clutch (eggs), MedDRA, Anaphylaxis, Data collection, Multi, Registry, Infant, International Society, Collection, Incidence, Clinical study design, FD, Replication (computing), Deference, Failure, CDM, Innovation Center station, Prevalence, Diagnosis, Mortality, Pregnancy, Person, Data analysis, Classification, Committee, Knowledge, Silver, PMID, Development, Roger Hawkins (drummer), Record, Len Bias, 1113, Polypharmacy, Sensitivity analysis, Protocol, Risk, European Medicines Agency, FDA, Real, Joint, Step, Quality control, Documentation, Standard of care, Health care, Accident, Checklist, Database, Birth weight, Statistics, Communication, Natural language processing, Table, Data Governance Act, Common data model, Study, Reproduction, Quality assurance, European, BMJ, Quality, Conducting, Comorbidity, NMPA, Knowledge Organization (journal), Drug development, DHT, Conceptual, ISPE, Adrenaline, Marketing, Cancer, EHR, Phenotype, Safety, Rehabilitation, Research design, HCPCS, Treatment, Allergy, Electronic health record, Validity, Death, MAH, Quality of life, 1128, Confidentiality, Selection bias, Prescription, Machine learning, Duration, CIOMS, Vaccine, ICMJE, Injury, Workplace, Section 5, National Cancer Institute, Bangladesh Technical Education Board, Interval (mathematics), Regulation, Data quality, Management, GCP, Digital, Software, Meta-analysis, SNOMED, Section 8, Use, Biology, QC, Uncertainty, Birth defect, PPV, FDN, Publication bias, Draft, Shareware, Frailty, Disulfiram-like drug, Guideline, Publishing, Gestational diabetes, De novo, Big data, Conduct, Medication, Bias, Immunodeficiency, EMA, Social media, International Classification of Diseases, History, Name, Data management, M10, Algorithm, Ageing, Natural history, SAP, Asian literature, Disability, QA/QC, Immortal, NDC, Book, Human voice, Central Statistics Office (India), Content, Birth, Frontiers Media, Metadata, RxNorm, Data governance, GPP, Structuring, Radiology, Benzodiazepine, Lash, User experience, Theft, Methodology, Objective, RWD, COMMUNICATION, DATA, Literature, Health information management, Clinical trial, Dependent and independent variables, Research, Patient, ATC, INTRODUCTION, TB, Section 13, Contraindication, Insurance, Concomitant, Data, Index, M14, Gestational age, Data curation, Biomarker, ICH, Paper, CHMP, Medical device

Key Points: 

    Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence

    Retrieved on: 
    火曜日, 5月 28, 2024

    11

    Key Points: 
      • 11

        Reflection paper on use of real-world data in noninterventional studies to generate real-world evidence

        12

        Table of contents

        13

        1.

      • References ............................................................................................ 15

        10

        Reflection paper on use of real-world data in non-interventional studies to generate
        real-world evidence
        EMA/CHMP/150527/2024

        Page 2/16

        44

        1.

      • Introduction

        45

        This reflection paper discusses methodological aspects of non-interventional studies (NIS) using real-

        46

        world data (RWD) in order to generate real-world evidence (RWE) for regulatory purposes.

      • These include absence of randomisation, uncontrolled conditions, non-

        61

        standardised treatments and uncertainties regarding data quality and completeness.

      • The

        63

        increasing ability to capture electronic healthcare data and data from registries is now providing new

        64

        opportunities to use RWD and generate RWE that reflects clinical practice.

      • Scope

        89

        The scope of this reflection paper is the design, conduct and analysis of NIS using RWD to generate

        90

        RWE for regulatory purposes.

      • data collected specifically for the study in

        106

        question, or secondary use of existing data sources.

      • In both cases, attention should be paid to the

        107

        possible selection mechanisms in the data collection, for example the inclusion of specific patients or

        108

        the collection of specific clinical data.

      • Reference to studies with causal objectives in this document does not

        119

        imply an expectation that specific analytical methods will be used.

      • Reflection paper on use of real-world data in non-interventional studies to generate
        real-world evidence
        EMA/CHMP/150527/2024

        Page 4/16

        128

        The legal obligations and regulatory requirements applicable to NIS should be followed.

      • 138

        ?

        Regulation (EU) 2016/679 on the protection of natural persons with regard to the processing of

        139
        140

        personal data and on the free movement of such data.

      • The specific aim of the study forms the basis for the

        164

        selection of data source(s), study design, and analysis approach.

      • Reflection paper on use of real-world data in non-interventional studies to generate
        real-world evidence
        EMA/CHMP/150527/2024

        Page 5/16

        166

        4.2.

      • Reflection paper on use of real-world data in non-interventional studies to generate
        real-world evidence
        EMA/CHMP/150527/2024

        Page 6/16

        208

        ?

        Regional differences in clinical practice and healthcare systems management, e.g.

      • Misclassification can arise at many different

        296

        steps of data collection and extraction: diagnosis, coding, recording, data transformation, data

        297

        aggregation, summarisation, and analysis.

      • Reflection paper on use of real-world data in non-interventional studies to generate
        real-world evidence
        EMA/CHMP/150527/2024

        Page 12/16

        452

        6.4.

      • For these studies, the study protocol should describe:

        456

        ?

        The data elements used to link the data.

      • Heterogeneity

        530

        In multi-database studies, different estimates may be found even when the same protocol is applied

        531

        across all data sources (22).

      • (2023)
        Reflection paper on use of real-world data in non-interventional studies to generate
        real-world evidence
        EMA/CHMP/150527/2024

        Page 15/16

        569
        570

        15.

      • Draft guidance Real-World Data: Assessing Electronic Health Records and Medical Claims
        Data To Support Regulatory Decision-Making for Drug and Biological Products (2021)

        571
        572
        573

        16.

      • Reflection paper on use of real-world data in non-interventional studies to generate
        real-world evidence
        EMA/CHMP/150527/2024

        Page 16/16

    LV Distribution and NewVest Establish Strategic Partnership to Facilitate Better Access to Private Markets Investing

    Retrieved on: 
    火曜日, 3月 19, 2024

    NEW YORK, March 19, 2024 /PRNewswire/ -- LV Distribution, specializing in third-party asset management distribution, proudly announces a groundbreaking partnership with NewVest, the first-of-its-kind platform of index funds for the private markets.

    Key Points: 
    • NEW YORK, March 19, 2024 /PRNewswire/ -- LV Distribution, specializing in third-party asset management distribution, proudly announces a groundbreaking partnership with NewVest, the first-of-its-kind platform of index funds for the private markets.
    • This collaboration marks a transformative moment for LV Distribution as it ventures into the realm of private markets, bringing institutional-quality investment strategies to Registered Investment Advisors (RIAs) and Family Offices.
    • "We are thrilled to partner with NewVest, a pioneering investment manager that is seeking to redefine how investors can establish core, diversified exposure to private equity, private debt and other private markets strategies," said Edward Soltys, Head of LV Distribution.
    • The LV Distribution and NewVest partnership exemplifies a commitment to providing innovative, accessible solutions for navigating the complexities of private markets.

    Philadelphia hopes year-round schooling can catch kids up to grade level – will it make a difference?

    Retrieved on: 
    火曜日, 2月 13, 2024

    Upon becoming mayor of Philadelphia, Cherelle Parker announced that she will establish a working group on full-day and year-round schooling – an idea she had supported while campaigning.

    Key Points: 
    • Upon becoming mayor of Philadelphia, Cherelle Parker announced that she will establish a working group on full-day and year-round schooling – an idea she had supported while campaigning.
    • The group will develop a strategy to keep Philadelphia public schools open for longer hours during the week, from 7:30 a.m. to 6 p.m., as well as over the summer, and to provide “meaningful, instructive out-of-school programming and job opportunities for students.” Below, education expert Daniel H. Robinson answers five questions about year-round schooling in Philadelphia.

    What do we know about the mayor’s plan?

    • It does not state how many days or hours will be added to the 180 days Philadelphia currently requires.
    • For example, students might have 45 school days followed by 15 days of break, or 60 school days followed by 20 days of break.
    • The report suggested that the school year should be increased to 200 to 220 days.

    How prevalent is year-round schooling?

    • Japan and Australia have school for almost the entire year, while the U.S. has school for only about nine months.
    • But they still maintain traditional school hours during the school year.
    • This three-year initiative involves 40 schools that will add 300 hours to their existing school calendar by having either longer days, longer school years or both.

    Can the mayor legally do this?

    • The Philadelphia mayor can certainly extend the school day and the school hours since she appoints the school board members, who in turn control who is hired or fired as superintendent.
    • A more important question is: Should the mayor do this?
    • Despite the hope that longer school days or years will lead to gains in student achievement, there’s little evidence that they will.
    • A better evaluation plan would be to first solicit applications for the pilot program from the more than 200 Philadelphia schools.

    What are the potential gains?

    • It makes it easier for them to drop off and pick up kids on their way to and from work.
    • It also provides kids a safe and supportive environment for more hours.
    • Keeping kids at school longer during the day and for more days during the year can lower juvenile crime.

    What hurdles might year-round schooling face in Philly?

    • Many Philly public schools do not have adequate air conditioning to be open throughout the hot summer months.
    • More Philadelphia teachers are quitting or retiring than those who are being newly trained, according to the report.


    Daniel H. Robinson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

    Demographics, labor market power and the spatial equilibrium

    Retrieved on: 
    火曜日, 2月 13, 2024

    Abstract

    Key Points: 
      • Abstract
        This paper studies how demographics affect aggregate labor market power, the urban wage
        premium and the spatial concentration of population.
      • I develop a quantitative spatial model
        in which labor market competitiveness depends on the demographic composition of the local
        workforce.
      • If these factors differ across workers, labor market power has a role to
        play in explaining wage inequality.
      • This paper contributes to the literature on differences in labor market power by analyzing a
        new dimension of heterogeneity: demographics.
      • Since older workers are less mobile in terms of
        switching workplaces, firms have more labor market power over older workers.
      • I start by estimating labor market power by measuring the sensitivity of worker turnover to
        the wage paid.
      • I find a strong
        role of demographics in determining the degree of labor market power enjoyed by firms.
      • Next, I provide evidence of the importance of differences in labor market power for spatial
        wage inequality.
      • To explore the consequences of labor market sorting, I build a spatial general equilibrium
        model in which labor market competitiveness depends on the demographic composition of the

        ECB Working Paper Series No 2906

        2

        local workforce.

      • If these factors differ across workers, labor market power has a role to
        play in explaining wage inequality.
      • In
        the model, geographic sorting by age matters and leads to higher labor market power in rural
        areas, which implies an urban wage premium that is 4% larger than with uniform labor supply
        elasticities.
      • I follow Manning (2013) and estimate labor market power by measuring the sensitivity of worker
        turnover to the wage paid.
      • Bachmann et al., 2021; Ahlfeldt et al., 2022a; Berger et al.,
        2022) that nest a monopsonistic labor market in a spatial general equilibrium model (Redding
        and Rossi-Hansberg, 2017).
      • As firms have more labor market power
        over older workers, they face an upward-sloping labor supply curve that is less elastic in regions
        with an older workforce.
      • Firms choose in which labor market to operate in the sense that there is free
        entry at fixed costs into all locations.
      • How are differences in labor market competitiveness across space sustained in spatial equilibrium?
      • I use the model to quantify the importance of heterogeneity
        in labor market power for the urban wage premium and the spatial concentration of population.
      • My work is complementary to but quite different
        from this paper since I argue that population aging increases labor market power rather than
        product market power.
      • By analyzing the effects of a changing age composition of the workforce in the context
        of labor market power, I relate to literature on the labor market effects of population aging.
      • ECB Working Paper Series No 2906

        7

        after controlling for age, differences in labor market power between East and West Germany
        vanish.

      • They conclude that higher
        concentration is associated with higher labor market power (as in the model of Jarosch et al.,
        forthcoming).
      • I offer an alternative explanation why labor market power differs across regions:
        Since denser regions have a younger workforce, workers are more mobile in terms of switching
        jobs which implies lower labor market power of firms.
      • In this case, I infer a
        high labor supply elasticity and low labor market power of firms.
      • I contribute to this growing debate by
        quantifying differences in labor market power across worker groups and their effects on regional
        inequality.
      • While the model shows how demographics affect labor market power, the urban wage premium and agglomeration, one fundamental question remains open for future research: What
        are the policy implications of (differences in) labor market power?

    Kahoot! earns Level III Certification for Alignment with ESSA, proving requirements for positive student learning outcomes

    Retrieved on: 
    金曜日, 1月 26, 2024

    OSLO, Norway, Jan. 26, 2024 /PRNewswire/ -- Kahoot!, the global learning and engagement platform company, today announced it has earned Level III certification for its alignment with standards outlined by the Every Student Succeeds Act (ESSA). This certification demonstrates "Promising Evidence" of Kahoot!'s efficacy in driving positive learning outcomes for students.

    Key Points: 
    • satisfies Every Student Succeeds Act (ESSA) Level III certification requirements.
    • OSLO, Norway, Jan. 26, 2024 /PRNewswire/ -- Kahoot!, the global learning and engagement platform company, today announced it has earned Level III certification for its alignment with standards outlined by the Every Student Succeeds Act (ESSA).
    • "With Level III certification in the ESSA evidence standards, educators and administrators can now be even more confident that using Kahoot!
    • is supported by a properly designed and implemented correlational study, statistically controlling for selection bias, and showing a statistically significant positive effect on student learning outcomes.

    NeoGenomics and ConcertAI Announce Collaboration to Advance Population-Scale, Definitive Hematological Research & Generative AI Solutions at ASH 2023

    Retrieved on: 
    月曜日, 1月 8, 2024

    Hematological malignancies require surveillance of patients over multiple time periods with numerous clinical and diagnostic measures to assess sustained response to treatment or relapse.

    Key Points: 
    • Hematological malignancies require surveillance of patients over multiple time periods with numerous clinical and diagnostic measures to assess sustained response to treatment or relapse.
    • Combining ConcertAI's longitudinal clinical data with NeoGenomics' comprehensive biomarkers derived from hundreds of hematological tests we are able to establishe a robust and definitive RWE hematology solution.
    • The collaboration advances molecular and genetic data solutions for the entire drug development lifecycle, from early clinical development to post-approval epidemiological studies.
    • "ConcertAI has spent the last three years with biopharma researchers, medical societies, patient advocacy groups, and academic teams to define requirements for truly definitive, insight-enabling research solutions for hematological malignancies," said Jeff Elton, PhD, CEO of ConcertAI.

    Does picking your nose really increase your risk of COVID?

    Retrieved on: 
    木曜日, 8月 3, 2023

    Picking your nose is linked to an increased risk of COVID, according to a study out today.

    Key Points: 
    • Picking your nose is linked to an increased risk of COVID, according to a study out today.
    • Read more:
      When you pick your nose, you're jamming germs and contaminants up there too.

    What did the study find?

      • They had regular antibody testing, which tells us if they had been exposed to SARS-CoV-2, the virus that causes COVID.
      • Just over 17% of health workers who reported picking their nose caught COVID versus about 6% of those who did not report nose picking.
      • At first glance, it might appear feasible that people who pick their noses would be at increased risk of contracting COVID.

    Hang on a minute

      • For example, people who picked their noses only monthly had a higher chance of infection than daily nose pickers.
      • Logically, you would expect the daily nose pickers to have a higher risk of infection due to more transmission opportunities.
      • There were also several aspects of how the study was designed that may have influenced the results.
      • Just over half of the people approached to participate in the study actually did so, which may cause selection bias.
      • This is where people who choose to participate may differ in some key characteristic from those who don’t.

    So, what now?

      • Overall, the risk of SARS-CoV-2 transmission via nose picking is probably comparatively low, particularly for the general public who are not working in high COVID environments.
      • But you can definitely decrease your risk through good hand hygiene (and using a tissue that you dispose of afterwards).